---
$id: https://graph.org.ai/products/commodity/51171906
$type: Product
source: UNSPSC
code: "51171906"
title: "Lansoprazole"
class: "51171900"
classTitle: "Antiulcer and related gastrointestinal GI drugs"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lansoprazole

**UNSPSC Code**: 51171906
**Class**: [Antiulcer and related gastrointestinal GI drugs](Antiulcer and related gastrointestinal GI drugs.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a proton pump inhibitor with the molecular formula C16H14F3N3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0K5C5T2QPG, chemically known as 2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole but generally known as lansoprazole, which bears US NIH Compound Identifier 3883. European Medicines Agency schedules Lansoprazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08403MIG. The term LANSOPRAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). World Health Organization schedules lansoprazole in its Anatomical Therapeutic Chemical (ATC) Classification. LANSOPRAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lansoprazole under HS 29333999 and SITC 51574. As of Q4 2014, LANSOPRAZOLE remains the US FDA Preferred Term for this commodity. Lansoprazole bears US NLM identifiers UMLS ID C0286036 and NCI Concept Code C29150. SMILES: S(=O)(CC1NCCC(OCC(F)(F)F)C1C)C1[NH]C2C(N1)CCCC2.

